### RBM14-RBM4 Gene Overview:
The RBM14-RBM4 gene locus is characterized by read-through transcription between the adjacent RBM14 and RBM4 genes. The resultant gene product includes a fusion protein that retains functional domains from both original proteins, indicating a role in regulatory processes such as transcriptional activation.

### 1. Associated Genes:
In addition to RBM14 and RBM4, the RBM14-RBM4 locus may interact with several other genes involved in RNA processing and transcriptional regulation. While specific gene interactions are context-dependent and might vary, common associated genes may include:
- **RBMX** (RNA binding motif protein, XY-like)
- **RBPMS** (RNA binding motif protein, single stranded)
- **UBR5** (Ubiquitin protein ligase E3 component N-recognin 5), which may show connections in gene regulation and stability pathways.
- **SR proteins**, which are also involved in splicing.

### 2. Aging and Age-Related Disease Associations:
While direct contributions of RBM14-RBM4 to aging or age-related diseases are not extensively documented, RNA binding proteins (RBPs) like RBM14 and RBM4 are known to play roles in the regulation of gene expression, splicing, and the stability of mRNA. Dysregulation of RBPs has been linked to various age-associated conditions such as:
- Neurodegenerative diseases (e.g., Alzheimer's disease) due to altered RNA metabolism.
- Cancer, as mutations and changes in expression of RBPs are implicated in tumor progression and metastasis.

Further research may be necessary to elucidate specific pathways through which RBM14-RBM4 influences age-related molecular processes or contributes explicitly to related diseases.

### 3. Drug Dependencies and Interactions:
While there is limited direct information on specific drugs interacting with RBM14-RBM4, RNA binding proteins broadly are subject to modulation by certain classes of therapeutics, including:
- **Antisense oligonucleotides**: These can target specific mRNA species that may be influenced by RBM14 or RBM4 functions.
- **Histone deacetylase inhibitors (HDACi)**: Such as Vorinostat, which can impact transcriptional regulation processes potentially involving RBM proteins.
Direct involvement of RBM14-RBM4 with particular drugs has not been well-established, and experimental studies would be essential to clarify such interactions.

### 4. Pathways and Biological Processes:
The RBM14-RBM4 fusion protein is reported to participate in multiple biological pathways, including:
- **Transcriptional activation**: RBM proteins are known to influence gene expression in a hormone-dependent manner. 
- **RNA splicing**: As an RNA-binding protein, RBM4 may play a part in the alternative splicing of pre-mRNA, while RBM14 may participate in nuclear retention and modification of spliced mRNAs.
- **Protein-protein interactions**: Interaction with other regulatory proteins, possibly affecting signal transduction pathways.

Research is ongoing to define the full breadth of biological processes involving RBM14-RBM4 and its functional implications in both normal physiology and disease states. Further investigation into specific pathways such as cell cycle regulation, apoptosis, and response to stress may yield additional insights into its role.